Literature DB >> 29523693

Antibody receptors steal the sweet spotlight.

Kelsey D Oliva1, Jill M Cavanaugh1, Brian A Cobb2.   

Abstract

Immunoglobulin G (IgG) antibodies function, in part, through ligation of cell-surface Fc receptors such as FcγRIIIA (also known as CD16A). IgG glycosylation is known to impact antibody function, but the role of FcγRIIIA glycans, if any, is unclear. Patel et al. now reveal that these glycans do impact protein conformation and IgG affinity and display cell-specific glycosylation patterns, leading to a potential model in which the affinity and possibly function of Fc receptors is dictated by the cell type and its surface glycome.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29523693      PMCID: PMC5846142          DOI: 10.1074/jbc.H118.001955

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

3.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 4.  Properties of mouse and human IgG receptors and their contribution to disease models.

Authors:  Pierre Bruhns
Journal:  Blood       Date:  2012-04-25       Impact factor: 22.113

5.  Glycoimmunology: ignore at your peril!

Authors:  Linda G Baum; Paul R Crocker
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

Review 6.  Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma.

Authors:  D R Anderson; A Grillo-López; C Varns; K S Chambers; N Hanna
Journal:  Biochem Soc Trans       Date:  1997-05       Impact factor: 5.407

Review 7.  Infection, inflammation and host carbohydrates: a Glyco-Evasion Hypothesis.

Authors:  Lori Sc Kreisman; Brian A Cobb
Journal:  Glycobiology       Date:  2012-04-05       Impact factor: 4.313

8.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

9.  Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.

Authors:  Kashyap R Patel; Jacob T Roberts; Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

  9 in total
  4 in total

1.  CD16a with oligomannose-type N-glycans is the only "low-affinity" Fc γ receptor that binds the IgG crystallizable fragment with high affinity in vitro.

Authors:  Ganesh P Subedi; Adam W Barb
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

Review 2.  Inside-Out Control of Fc-Receptors.

Authors:  Leo Koenderman
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

Review 3.  Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid.

Authors:  Sharon Yehuda; Vered Padler-Karavani
Journal:  Front Immunol       Date:  2020-01-23       Impact factor: 7.561

Review 4.  Dendritic cell biology and its role in tumor immunotherapy.

Authors:  Yingying Wang; Ying Xiang; Victoria W Xin; Xian-Wang Wang; Xiao-Chun Peng; Xiao-Qin Liu; Dong Wang; Na Li; Jun-Ting Cheng; Yan-Ning Lyv; Shu-Zhong Cui; Zhaowu Ma; Qing Zhang; Hong-Wu Xin
Journal:  J Hematol Oncol       Date:  2020-08-03       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.